Personals Sign In / Join
Username:
 Password:
Back to home » Top Stories » ICAAC 2007

emailrssprint

New Data Explores Current Treatment Options

September 19, 2007

At the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Peter Staley asks Dr. Joe Eron about the good news on a challenging drug – newly-approved Selzentry – and the very potent new protease inhibitor, Prezista.



13 minutes. Click here to view the transcript.

NEW! Scroll down to comment on this story.

emailrssprint


Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

       


[Go to top]


September 20, 2007
Wisdom for Women: An Expert's Take on HIV and Gender Differences
Peter Staley asks Dr. Sharon Walmsley what women need to know about HIV and antivirals, and gender differences needing more research.
September 19, 2007
Coming Down the Pike: Expanding HIV Treatment Options
Peter Staley asks Dr. Joe Eron about the latest data on soon-to-be-approved Isentress and an entry inhibitor you might inject just once every other week.
New Data Explores Current Treatment Options
Peter Staley asks Dr. Joe Eron about the good news on a challenging drug -- newly-approved Selzentry -- and the very potent new protease inhibitor, Prezista.
September 18, 2007
Secrets of a Long-Term Survivor
Peter Staley talks with Matt Sharp about his activism, his new regimen, and his facial lipo fix.
Interview with a Hep C Activist & Survivor
Peter Staley interviews Jules Levin, an activist and survivor of hepatitis C and HIV coinfection, about the latest in HCV treatment and prevention.


© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy